MedicineWatch US

Northwind Pharmaceuticals LLC Provisional

Indianapolis, IN · united states

8 recall flag(s)

FDA Flags (8)

Class II RecallSep 2025
Northwind Pharmaceuticals LLC
Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottles (NDC 51655-3
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
BusPIRone Hydrochloride Tablets USP, 7.5 mg, 30-count bottles, Rx Only, Repackaged By: NOrthwind Pharmaceuticals, Indian
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapo
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203
Classification: Class II
Class II RecallMay 2023
Northwind Pharmaceuticals LLC
Glimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDC 51655-120
Classification: Class II